The 50-minute session will focus on safety concerns with labelling of IV fluids, strategies to mitigate fluoropyrimidine toxicity and the National System for Incident Reporting transition.
A new study explores how 'essentially placebo' treatments raise questions about the transparency and trust that underpin the doctor-patient relationship.
Instead, the task force says clinicians should make asking about a patient’s mental health and well-being a part of their usual care and use their own clinical judgement to detect signs of depression and decide of further steps.
